1. Home
  2. INM vs BTE Comparison

INM vs BTE Comparison

Compare INM & BTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INM
  • BTE
  • Stock Information
  • Founded
  • INM 1981
  • BTE 1993
  • Country
  • INM Canada
  • BTE Canada
  • Employees
  • INM N/A
  • BTE N/A
  • Industry
  • INM Biotechnology: Pharmaceutical Preparations
  • BTE Meat/Poultry/Fish
  • Sector
  • INM Health Care
  • BTE Consumer Staples
  • Exchange
  • INM Nasdaq
  • BTE Nasdaq
  • Market Cap
  • INM 3.2M
  • BTE 1.4B
  • IPO Year
  • INM N/A
  • BTE N/A
  • Fundamental
  • Price
  • INM $2.75
  • BTE $1.92
  • Analyst Decision
  • INM
  • BTE Hold
  • Analyst Count
  • INM 0
  • BTE 1
  • Target Price
  • INM N/A
  • BTE $5.50
  • AVG Volume (30 Days)
  • INM 5.7M
  • BTE 50.5M
  • Earning Date
  • INM 05-12-2025
  • BTE 07-24-2025
  • Dividend Yield
  • INM N/A
  • BTE 3.36%
  • EPS Growth
  • INM N/A
  • BTE N/A
  • EPS
  • INM N/A
  • BTE 0.28
  • Revenue
  • INM $4,920,990.00
  • BTE $2,327,227,884.00
  • Revenue This Year
  • INM N/A
  • BTE $3.43
  • Revenue Next Year
  • INM N/A
  • BTE N/A
  • P/E Ratio
  • INM N/A
  • BTE $6.65
  • Revenue Growth
  • INM N/A
  • BTE 10.55
  • 52 Week Low
  • INM $1.72
  • BTE $1.36
  • 52 Week High
  • INM $15.70
  • BTE $3.84
  • Technical
  • Relative Strength Index (RSI)
  • INM 46.31
  • BTE 52.86
  • Support Level
  • INM $2.66
  • BTE $1.86
  • Resistance Level
  • INM $2.97
  • BTE $2.03
  • Average True Range (ATR)
  • INM 0.37
  • BTE 0.10
  • MACD
  • INM -0.05
  • BTE -0.00
  • Stochastic Oscillator
  • INM 15.12
  • BTE 40.28

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

About BTE Baytex Energy Corp

Baytex Energy Corp is an oil and gas company. Geographically, the group operates in Canada and the United States. The company derives a majority of revenue from Canada. Its Canada segment includes the exploration, development, and production of crude oil and natural gas in Western Canada.

Share on Social Networks: